Advertisement

Topics

Astellas Pharma US,Inc Company Profile

22:17 EDT 23rd September 2018 | BioPortfolio

Launched in April 2005, Astellas was formed by the historical merger of Japan's third and fifth largest pharmaceutical companies - Yamanouchi, founded in 1923, and Fujisawa, founded in 1894.Both companies possessed similarities where it matters most- philosophy and vision. But the companies also differed where it matters most - areas of therapeutic concentration and expertise.
Yamanouchi brought a record of developing blockbuster drugs, a pipeline full of promising new compounds like Fujisawa, a sales and marketing culture of deeply grounded, data-driven expertise.
Fujisawa brought dominance in transplantation, a soaring reputation for in-depth understanding of the disease states and treatments within its market niches, and a track record for developing high-profile, market-leading products that become new standards of care.
With an unrelenting commitment to R&D as a value-creating core of its business, Astellas is consolidated around complementary strengths from Yamanouchi and Fujisawa. Astellas stands on a much stronger, more advanced business platform than either of the former companies could have mounted individually.

Location

3 Parkway North
Deerfield
Illinois
60015
United States of America

Contact

Phone: 800.695.4321
Email: Astellasreimbursement@quorumconsulting.com


News Articles [715 Associated News Articles listed on BioPortfolio]

Astellas Pharma Acquires Quethera

NewsThrough this transaction, Astellas has acquired Quethera's ophthalmic gene therapy program.

Astellas Pharma acquires Quethera for $108.5m

Japan-based Astellas Pharma has acquired British gene therapy company Quethera, which primarily develops new treatments for ocular diseases such as...Read More... The post Astellas Pharma acquires Que...

Astellas gibt Übernahme von Quethera bekannt

Übernahme fördert das Engagement von Astellas für Innovationen in der Augenheilkunde mit neuartigem Gentherapieprogramm für Glaukom Tokyo und Cambridge, England (ots/PRNewswire) - Astellas Pharma ...

FDA Approves Pfizer And Astellas Pharma's Xtandi

NewsThis approval makes Xtandi the first and only oral medication FDA-approved for both non-metastatic and metastatic castration-resistant prostate cancer (CRPC).

Astellas wins expanded label to include pediatric use for oral solifenacin

Tokyo-based Astellas Pharma has been awarded EU approval for its neurogenic detrusor overactivity (NDO)…

FDA priority review status granted to Astellas' AML drug

Astellas Pharma's gilteritinib, which is being developed as a treatment for adult patients with relapsed/refractory FLT3-posi -More- 

Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

TOKYO and BOTHELL, Wash., March 26, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced t...

Astellas reports on late-stage trial for chronic kidney disease drug

Astellas Pharma announced that the key endpoints were met for its Phase III study to evaluate its candidate roxadustat as a t -More- 

Drugs and Medications [250 Associated Drugs and Medications listed on BioPortfolio]

Vesicare [Astellas Pharma Technologies, Inc.]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. ...

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

Case 260.

History A 31-year-old woman with a history of bilateral orthotopic lung transplantation performed 10 months earlier for cystic fibrosis presented for a routine follow-up appointment, with her chief sy...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 5 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

The purpose of the study is to provide access to continued treatment for subjects who participated in other Astellas sponsored ASP2215 trials and for whom the Investigator feels the subjec...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Companies [775 Associated Companies listed on BioPortfolio]

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Global Development

Astellas Pharma Global Development, located in Deerfield, Illinois, is a group company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of peo...

Astellas Pharma Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

Potenza Therapeutics, Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and rel...

More Information about "Astellas Pharma US,Inc" on BioPortfolio

We have published hundreds of Astellas Pharma US,Inc news stories on BioPortfolio along with dozens of Astellas Pharma US,Inc Clinical Trials and PubMed Articles about Astellas Pharma US,Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astellas Pharma US,Inc Companies in our database. You can also find out about relevant Astellas Pharma US,Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Corporate Database Quicklinks



Searches Linking to this Company Record